Musa Tariq - 12 Jun 2025 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Director
Signature
/s/ John G. Saia, as attorney-in-fact for Musa Tariq
Issuer symbol
GH
Transactions as of
12 Jun 2025
Net transactions value
$0
Form type
4
Filing time
16 Jun 2025, 19:25:54 UTC
Previous filing
20 May 2025
Next filing
20 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Tariq Musa Director 3100 HANOVER STREET, PALO ALTO /s/ John G. Saia, as attorney-in-fact for Musa Tariq 16 Jun 2025 0001968281

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GH Common Stock Options Exercise $0 +6,674 +192% $0.000000 10,153 12 Jun 2025 Direct
transaction GH Common Stock Options Exercise $0 +250 +2.5% $0.000000 10,403 15 Jun 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH Restricted Stock Units Options Exercise $0 -6,674 -100% $0.000000 0 12 Jun 2025 Common Stock 6,674 $0.000000 Direct F1, F2
transaction GH Restricted Stock Units Options Exercise $0 -250 -4.5% $0.000000 5,247 15 Jun 2025 Common Stock 250 $0.000000 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units vest in full on the one-year anniversary of the grant date, June 12, 2024 or the date of the next year annual stockholders meeting, whichever is earlier.
F2 Not applicable for Restricted Stock Units.
F3 The restricted stock units granted on March 6, 2023 vests over a four-year period. 25% of the shares subject to such award vested on the one-year anniversary of March 15, 2023 and the remaining 75% vests monthly for the three-year period thereafter.